Skip to main content

Type of Therapy and Quality of Life in Atrial Fibrillation

  • Conference paper
New Advances in Heart Failure and Atrial Fibrillation
  • 100 Accesses

Abstract

Atrial fibrillation (AF) is a frequent and costly health care problem. In patients with AF, the restoration and maintenance of sinus rhythm is the primary therapeutic goal. The most frequent strategy for maintaining sinus rhythm after its restoration is the use of antiarrhythmic drugs. The efficacy of therapy in AF has been predominantly measured using objective criteria such as mortality and morbidity. In recent years, the importance of quality of life as an outcome measure has been recognized. However, few studies in the literature have examined quality of life in patients with AF using properly validated tools. In addition, the specific impact of antiarrhythmic treatment on quality of life in patients with AF has not been assessed. These issues are now being addressed in several ongoing studies. This article attempts to define quality of life, makes recommendations on how quality of life might be assessed, and reviews our current knowledge regarding quality of life in patients with AF.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 155:469–473

    Article  PubMed  CAS  Google Scholar 

  2. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA (1994) Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 271:840–844

    Article  PubMed  CAS  Google Scholar 

  3. Kannel WB, Wolf PA, Benjamin EJ, Levy D (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N–9N

    Article  PubMed  CAS  Google Scholar 

  4. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE (1995) The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98:476–484

    Article  PubMed  CAS  Google Scholar 

  5. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952

    Article  PubMed  CAS  Google Scholar 

  6. Luderitz B, Jung W (2000) Quality of life in patients with atrial fibrillation. Arch Intern Med 160:1749–1757

    Article  PubMed  CAS  Google Scholar 

  7. Jung W, Luderitz B (1998) Quality of life in patients with atrial fibrillation. J Cardiovasc Electrophysiol 9 [Suppl 8]:5177–5186

    Google Scholar 

  8. Crijns HJGM, Van Gelder IC, Tieleman RG, Gosselink ATM, Van den Berg MP (1997) Why is atrial fibrillation bad for you? In: Murgatroyd FD, Camm AJ (eds) Nonpharmacological management of atrial fibrillation. Futura, Armonk, pp 3–13

    Google Scholar 

  9. Schumacher B, Luderitz B (1998) Rate issues in atrial fibrillation: consequences of tachycardia and therapy for rate control. Am J Cardiol 82:29N–36N

    Article  PubMed  CAS  Google Scholar 

  10. Lönnerholm S, Blomström P, Nilsson L, Oxelbark S, Jideus L, Blomström-Lundqvist C (2000) Effects of the Maze operation on health-related quality of life in patients with atrial fibrillation. Circulation 101:2607–2611

    Article  PubMed  Google Scholar 

  11. Wellens JJW, Lau CP, Luderitz B, Akhtar M, Waldo A, Camm AJ, Timmermans C, Tse HF, Jung W, Jordaens L, Ayers G, for the METRIX Investigators (1998) Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation 98:1651–1656

    CAS  Google Scholar 

  12. Luderitz B, Jung W (2000) Quality of life in atrial fibrillation. J Intery Card Electrophysiol 4:201–209

    Article  Google Scholar 

  13. Savelieva I, Paquette M, Dorian P, Luderitz B, Camm AJ (2001) Quality of life in patients with silent atrial fibrillation. Heart 85:216–217

    Article  PubMed  CAS  Google Scholar 

  14. Wyse DG (2000) The AFFIRM trial: main trial and substudies - what can we expect? J Intery Card Electrophysiol 4:171–176

    Article  Google Scholar 

  15. Heinz G, Siostrzonek P, Kreiner G, Gossinger H (1992) Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol 69:489–492

    Article  PubMed  CAS  Google Scholar 

  16. Twidale N, Sutton K, Bartlett L, Booley A, Winstanley S, Heddle W, Hassam R, Koutsounis H (1993) Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias. Pacing Clin Electrophysiol 16:1275–1284

    Article  PubMed  CAS  Google Scholar 

  17. Rodriguez LM, Smeets JL, Xie B, de Chillou C, Cherix E, Pieters F, Metzger J, den Dulk K, Wellens HJJ (1993) Improvement in left ventricular function by ablation of atrio-ventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol 72:1137–1141

    Article  PubMed  CAS  Google Scholar 

  18. Brignole M, Gionfranchi L, Menozzi C, Bottoni N, Bollini R, Lolli G, Oddone D, Giaggioli G (1994) Influence of atrioventricular junction radiofrequency ablation patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol 74:242–246

    Article  PubMed  CAS  Google Scholar 

  19. Edner M, Caidahl K, Bergfeldt L, Darpö B, Edvardsson N. Rosenqvist M (1995) Prospective study of left ventricular function after radiofrequency ablation of atrio-ventricular junction in patients with atrial fibrillation. Br Heart J 74:261–267

    Article  PubMed  CAS  Google Scholar 

  20. Fitzpatrick AP, Kourouyan HD, Siu A, Lee RJ, Lesh MD, Epstein LM, Griffin JC, Scheinman NM (1996) Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J 131:499–507

    Article  PubMed  CAS  Google Scholar 

  21. Natale A, Zimerman L, Tomassoni G, Kearney M, Kent V, Brandon MJ, Newby K (1996) Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response. Am J Cardiol 78:1431–1433

    Article  PubMed  CAS  Google Scholar 

  22. Steinbeck G (1996) Drug therapy of atrial fibrillation: control of heart rate versus establishing sinus rhythm (in German). Z Kardiol 85[Suppl 61:69–74

    Google Scholar 

  23. Bathina MN, Mickelsen S, Brooks C, Jaramillo J, Hepton T, Kusumoto FM (1998) Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Am J Cardiol 82:589–593

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Italia

About this paper

Cite this paper

Lüderitz, B. (2003). Type of Therapy and Quality of Life in Atrial Fibrillation. In: Gulizia, M. (eds) New Advances in Heart Failure and Atrial Fibrillation. Springer, Milano. https://doi.org/10.1007/978-88-470-2087-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2087-0_13

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2169-3

  • Online ISBN: 978-88-470-2087-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics